Clinical trial Recruiting at 8 sites Observational Ages 18 and up

Identifying biomarkers for healing diabetic foot ulcers

Official title: Predictive and Diagnostic Biomarkers for Diabetic Foot Ulcers: Open Wound Master Study

Run by University of Michigan · NCT06104969 · Data updated 2026-11-12

This study is trying to find specific markers in the body that can help predict which diabetic foot ulcers are likely to heal, so doctors can better manage treatment for patients with these wounds.

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment5000 (estimated)
SponsorUniversity of Michigan
Academic / other
Drugs / interventionschemotherapy, radiation
Locations9 sites (Tucson, Arizona and 8 other locations)
StatusRecruiting
StartedJune 15, 2023
Main results expectedJune 15, 2028
Study endsJune 15, 2028
Registry record updatedSeptember 9, 2026
Trial IDNCT06104969 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 18 and older with clinically diagnosed diabetes and an open diabetic foot ulcer.

Probably not a fit

Patients with gangrene in the foot or those currently undergoing radiation or chemotherapy may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational platform study aims to test multiple biomarkers to determine which diabetic foot ulcers (DFUs) are more likely to heal. By collecting various biospecimens and clinical data from patients with active DFUs in outpatient settings, the study seeks to inform personalized management decisions and enhance future clinical trials for wound healing interventions. The flexible design allows for a wide range of studies relevant to DFUs, ensuring comprehensive data collection and analysis.

Why it matters

Potential benefit: If successful, this study could lead to improved personalized treatment strategies for patients with diabetic foot ulcers.

How similar studies have gone: Other studies have shown promise in using biomarkers for wound healing, but this platform approach is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Provision of signed and dated informed consent form.
2. Age 18 years or older.
3. Clinically diagnosed with diabetes or meeting the American Diabetes Association (ADA) criteria. \[ADA Standards of Clinical Care Diabetes Care 2022, Suppl 1\]
4. Open foot ulcer, defined as an open wound from malleolus down. This includes post-surgical wounds within this area left open to heal by secondary intention. In case of multiple ulcers, the largest ulcer will be considered the study index DFU.
5. Agreement to adhere to protocol visits and provide all required biospecimens and clinical data.

Exclusion Criteria:

1. Participation in an interventional clinical trial for DFU within 1 month of Visit 1.
2. Currently receiving radiation to target area or chemotherapy.
3. Gangrene in any portion of the foot with the index ulcer.
4. Planned revascularization or under evaluation for revascularization of the index limb for advanced ischemia within next 4 weeks of Week 0.
5. Severe limb ischemia (SVS WIfl Ischemia grade 3).
6. Any concomitant medical or psychiatric condition that, in the opinion of the investigator(s), would compromise the participant's ability to safely complete the study.

Where it's running

  • University of Arizona College of Medicine
    Tucson, Arizona, United States
    Recruiting
  • University of California - San Francisco
    San Francisco, California, United States
    Recruiting
  • Emory University School of Medicine
    Atlanta, Georgia, United States
    Recruiting
  • Beth Israel Deaconess Medical Center
    Boston, Massachusetts, United States
    Recruiting
  • University of Michigan
    Ann Arbor, Michigan, United States
    Recruiting
  • Northwell Health
    Lake Success, New York, United States
    Recruiting
Show 3 more locations
  • University of Pittsburgh
    Pittsburgh, Pennsylvania, United States
    Recruiting
  • University of Texas Health San Antonio
    San Antonio, Texas, United States
    Recruiting
  • University of Southern California
    Los Angeles, California, United States
    Suspended

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.